← Back to Patent Explorer
US4308027A Expired / Lapsed US ⏱️ 0.0 years remaining

Method and composition for direct determination of iron in blood serum

Assignee: RCC RICERCHE DI CHIMICA CLINICA Srl VIA G LEOPARDI 27 MILANO (ITALY) Soc
•
Filing: 1979-11-02
•
Granted: 1981-12-29
•
Expires: 1999-11-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A direct method for determination of iron in blood serum comprising reacting the blood serum with ferrozine in the presence of a reducing agent to bring iron ion into divalent form, thiosemicarbazide and hydrochloric acid at a pH between 1.7 and 2.1, without any addition of buffers and tensioactive agents and determining colorimetrically the iron content of the specimen by means of the colored complex formed between iron ion and ferrozine against a reagent blank.

Inventors

  • 👤 Ferruccio A. R. Ceriotti

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 15:44
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/84; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/106664

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 77 words
A direct method for determination of iron in blood serum comprising (a) reacting the blood serum with ferrozine in the presence of a reducing agent to bring iron ion into divalent form, thiosemicarbazide and hydrochloric acid at a pH between 1.7 and 2.1, without any addition of buffers and tensioactive agents and (b) determining colorimetrically the iron content of the specimen by means of the colored complex formed between iron ion and ferrozine against a reagent blank.
Claim 2
Dependent Claim 77 words
A direct method for determination of iron in blood serum comprising (a) reacting the blood serum with ferrozine in the presence of a reducing agent to bring iron ion into divalent form, thiosemicarbazide and hydrochloric acid at a pH between 1.7 and 2.1, without any addition of buffers and tensioactive agents and (b) determining colorimetrically the iron content of the specimen by means of the colored complex formed between iron ion and ferrozine against a reagent blank.
Claim 3
Dependent Claim 12 words
The method of claim 1 wherein the reducing agent is ascorbic acid.
Claim 4
Dependent Claim 27 words
The method of claim 1 wherein the concentration of hydrochloric acid in the test sample submitted to colorimetric measurement is ranging between 0.05 mol/l and 0.12 mol/l.
Claim 5
Dependent Claim 25 words
The method of claim 1 wherein the concentration of ferrozine in the test sample submitted to colorimetric determination amounts from 0.4 mg/ml to 1 mg/ml.
Claim 6
Dependent Claim 25 words
The method of claim 1 wherein the concentration of thiosemicarbazide in the test sample submitted to colorimetric determination amounts from 0.5 mg/ml to 1 mg/ml.
Claim 7
Dependent Claim 21 words
The method of claim 2 wherein the concentration of ascorbic acid in the test sample amounts to at least 1.5 mg/ml.
Claim 8
Dependent Claim 108 words
In a method for direct colorimetric determination of iron in blood serum by reacting the serum iron with ferrozine in the presence of acid and a reducing agent to release serum iron from transferrin and reduce iron ion to divalent form the improvement which comprises: carrying out the iron-ferrozine reaction in the presence of sufficient thiosemicarbazide to eliminate significant copper interference, without any addition of buffer and tensioaction agents and at a pH sufficiently low that such elimination of copper interference is obtained without significant reaction of the thiosemicarbazide with iron, said low pH also being such that substantially complete formation of a colored iron-ferrozine complex is obtained.
Claim 9
Dependent Claim 108 words
In a method for direct colorimetric determination of iron in blood serum by reacting the serum iron with ferrozine in the presence of acid and a reducing agent to release serum iron from transferrin and reduce iron ion to divalent form the improvement which comprises: carrying out the iron-ferrozine reaction in the presence of sufficient thiosemicarbazide to eliminate significant copper interference, without any addition of buffer and tensioaction agents and at a pH sufficiently low that such elimination of copper interference is obtained without significant reaction of the thiosemicarbazide with iron, said low pH also being such that substantially complete formation of a colored iron-ferrozine complex is obtained.
Claim 10
Dependent Claim 14 words
Method of claim 7 wherein the pH is from about 1.7 to about 2.1.
Claim 11
Dependent Claim 74 words
A kit for colorimetric determination of iron in blood serum without protein precipitation characterized in that the reagent mixture for colorimetric determination comprises hydrochloric acid, ascorbic acid, ferrozine and thiosemicarbazide and does not require addition of tensioactive agents, the amounts of hydrochloric acid, ferrozine and thiosemicarbazide being such that substantially complete reaction of ferrozine with iron in serum, and substantially complete elimination of copper interference without substantial reaction of iron with thiosemicarbazide is obtained.
Claim 12
Dependent Claim 74 words
A kit for colorimetric determination of iron in blood serum without protein precipitation characterized in that the reagent mixture for colorimetric determination comprises hydrochloric acid, ascorbic acid, ferrozine and thiosemicarbazide and does not require addition of tensioactive agents, the amounts of hydrochloric acid, ferrozine and thiosemicarbazide being such that substantially complete reaction of ferrozine with iron in serum, and substantially complete elimination of copper interference without substantial reaction of iron with thiosemicarbazide is obtained.
Claim 13
Dependent Claim 70 words
The kit of claim 9 whereby the reagent mixture is prepared in such a way that in the test sample submitted to colorimetric measurement the concentration of hydrochloric acid ranges between 0.05 mol/l and 0.12 mol/l, the concentration of ascorbic acid ranges between 5 mg/ml and 10 mg/ml, the concentration of ferrozine ranges between 0.4 mg/ml and 1 mg/ml and the concentration of thiosemicarbazide ranges between 0.5 mg/ml and 1/ml.
Claim 14
Dependent Claim 38 words
The kit of claim 10 whereby the reagent ferrozine is added as a concentrated solution to the reaction mixture and two photometric readings are made on the sample, one before and the other after the addition of ferrozine.
Claim 15
Dependent Claim 29 words
The kit of claim 9 whereby the reactants ferrozine and ascorbic acid and the thiosemicarbazide are added to the mixture of serum and hydrochloric acid in form of tablets.
Claim 16
Dependent Claim 21 words
A tablet for use in the kit of claim 12 which contains ferrozine and ascorbic acid together with an inert carrier.
Claim 17
Dependent Claim 32 words
A reagent composition for determination of iron in blood serum consisting essentially of ferrozine, thiosemicarbazide, ascorbic acid and sufficient hydrochloric acid to provide a pH of from about 1.7 to about 2.1.
Claim 18
Dependent Claim 32 words
A reagent composition for determination of iron in blood serum consisting essentially of ferrozine, thiosemicarbazide, ascorbic acid and sufficient hydrochloric acid to provide a pH of from about 1.7 to about 2.1.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-12-28 1985-06-29 1985-12-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-12-28 1989-06-29 1989-12-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-12-28 1993-06-29 1993-12-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag